We observed that MDM4 and MDM2 mRNA expression was elevated in primary breast invasive carcinomas of luminal A and luminal B molecular subtypes, as compared to HER2-enriched, basal, and normal-like subtypes (Figure 1, panels A and B). Here, MDM4 is linked to invasive breast carcinoma.